BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mwita JC, Francis JM, Oyekunle AA, Gaenamong M, Goepamang M, Magafu MGMD. Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana.Clin Appl Thromb Hemost. 2018;24:596-601. [PMID: 29258394 DOI: 10.1177/1076029617747413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Chebrolu P, Patil S, Laux TS, Al-Hammadi N, Jain Y, Gage B. Quality of anticoagulation with warfarin in rural Chhattisgarh, India. Indian J Med Res 2020;152:303-7. [PMID: 33107491 DOI: 10.4103/ijmr.IJMR_1201_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang N, Qiu S, Yang Y, Zhang C, Gu ZC, Qian Y. Physician-Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development. Front Pharmacol 2021;12:673302. [PMID: 34177585 DOI: 10.3389/fphar.2021.673302] [Reference Citation Analysis]
3 Lee SL, Ong TJ, Mazlan-Kepli W, Mageswaran A, Tan KH, Abd-Malek AM, Cronshaw R. Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. World J Cardiol 2021; 13(9): 483-492 [PMID: 34621493 DOI: 10.4330/wjc.v13.i9.483] [Reference Citation Analysis]
4 Nyamu DG, Guantai AN, Osanjo GO, Godman B, Aklillu E. Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya. Expert Review of Cardiovascular Therapy 2020;18:165-73. [DOI: 10.1080/14779072.2020.1734452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mouton JP, Blockman M, Sekaggya-Wiltshire C, Semakula J, Waitt C, Pirmohamed M, Cohen K. Improving anticoagulation in sub-Saharan Africa: What are the challenges and how can we overcome them? Br J Clin Pharmacol 2021;87:3056-68. [PMID: 33586223 DOI: 10.1111/bcp.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Semakula JR, Mouton JP, Jorgensen A, Hutchinson C, Allie S, Semakula L, French N, Lamorde M, Toh CH, Blockman M, Sekaggya-Wiltshire C, Waitt C, Pirmohamed M, Cohen K. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa. PLoS One 2020;15:e0227458. [PMID: 31995565 DOI: 10.1371/journal.pone.0227458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Noubiap JJ, Nyaga UF. A review of the epidemiology of atrial fibrillation in sub-Saharan Africa. J Cardiovasc Electrophysiol 2019;30:3006-16. [PMID: 31596016 DOI: 10.1111/jce.14222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ndadza A, Thomford NE, Mukanganyama S, Wonkam A, Ntsekhe M, Dandara C. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future. OMICS 2019;23:152-66. [PMID: 30883300 DOI: 10.1089/omi.2019.0018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Semakula JR, Kisa G, Mouton JP, Cohen K, Blockman M, Pirmohamed M, Sekaggya-Wiltshire C, Waitt C. Anticoagulation in sub-Saharan Africa: Are direct oral anticoagulants the answer? A review of lessons learnt from warfarin. Br J Clin Pharmacol 2021. [PMID: 33624331 DOI: 10.1111/bcp.14796] [Reference Citation Analysis]
10 Barrios V, Escobar C, Prieto L, Polo J, Muñiz J, Anguita M, H Lip GY. A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score. Future Cardiol 2021;17:685-92. [PMID: 33331173 DOI: 10.2217/fca-2020-0122] [Reference Citation Analysis]
11 Qiu S, Wang N, Zhang C, Gu ZC, Qian Y. Anticoagulation Quality of Warfarin and the Role of Physician-Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study. Front Pharmacol 2020;11:605353. [PMID: 33519468 DOI: 10.3389/fphar.2020.605353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yimer NS, Abiye AA, Hussen SU, Tadesse TA. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia. Clin Appl Thromb Hemost 2021;27:10760296211049786. [PMID: 34724849 DOI: 10.1177/10760296211049786] [Reference Citation Analysis]
13 Liyew Z, Tadesse A, Bekele N, Tsegaye T. Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia. Adv Hematol 2021;2021:7530997. [PMID: 34970315 DOI: 10.1155/2021/7530997] [Reference Citation Analysis]
14 Machado KLC, Rosa STD, Dobner S, Boettcher IS, Pasqualotto GC, Lopes AEL, Araújo T, Bolduan LPL, Colombo MDHP, Lacerda MP. Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil. Thromb Res 2021;205:81-3. [PMID: 34265606 DOI: 10.1016/j.thromres.2021.07.006] [Reference Citation Analysis]